FDA Diarrhea Drug Warning for Intestinomicina

The U.S. Food and Drug Administration (FDA) has issued a warning to not use Intestinomicina—a drug made in El Salvador to treat diarrhea and acute gastrointestinal infections—due to the presence of chloramphenicol, which can cause severe and life-threatening injuries.

According to the FDA, chloramphenicol can cause bone marrow toxicity. Bone marrow toxicity occurs when the body fails to produce enough red blood cells, white blood cells, or platelets. Patients who use Intestinomicina and are suffering from anemia, low white or red blood cell count or decreased blood platelets are at greater risk of serious injuries or death.

The drug also contains neomycin and sulfa drugs (sulfonamides) that can cause adverse reactions, ranging from rashes and hives, to severe and life-threatening reactions.

Intestinomicina is sold in tablet and liquid form at grocery stores in the United States that feature South and Central American specialty foods and products.

If you or someone you know has been harmed by a dangerous drug, contact Sokolove Law today for free legal consultation and to find out if a dangerous drugs lawyer may be able to help you.

Tags: